As of 2025-05-19, the Intrinsic Value of Dr Martens PLC (DOCS.L) is 84.66 GBP. This DOCS.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 61.05 GBP, the upside of Dr Martens PLC is 38.70%.
The range of the Intrinsic Value is 65.81 - 113.63 GBP
Based on its market price of 61.05 GBP and our intrinsic valuation, Dr Martens PLC (DOCS.L) is undervalued by 38.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 65.81 - 113.63 | 84.66 | 38.7% |
| DCF (Growth 10y) | 95.32 - 156.85 | 119.65 | 96.0% |
| DCF (EBITDA 5y) | 69.18 - 77.17 | 73.07 | 19.7% |
| DCF (EBITDA 10y) | 94.63 - 114.02 | 103.87 | 70.1% |
| Fair Value | 76.57 - 76.57 | 76.57 | 25.42% |
| P/E | 60.90 - 60.95 | 60.92 | -0.2% |
| EV/EBITDA | 60.93 - 60.97 | 60.95 | -0.2% |
| EPV | 174.04 - 235.93 | 204.99 | 235.8% |
| DDM - Stable | 17.16 - 29.49 | 23.32 | -61.8% |
| DDM - Multi | 41.80 - 57.06 | 48.32 | -20.8% |
| Market Cap (mil) | 586.02 |
| Beta | 1.22 |
| Outstanding shares (mil) | 9.60 |
| Enterprise Value (mil) | 932.83 |
| Market risk premium | 5.98% |
| Cost of Equity | 11.92% |
| Cost of Debt | 5.57% |
| WACC | 8.49% |